Pay in 4 interest-free payments of $5.28 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
DUAL GLUCAGON/GLUCAGON-LIKE PEPTIDE-1 RECEPTOR CO-AGONISTS As part of the ongoing effort to use synergistic effects of gastrointestinal hormones in the treatment of diabetes and obesity, the first GIP/GLP-1 receptor co-agonist was reported in 2013
Free shipment protection on every order Third-party tested CoA on file Discreet, tracked shipping Free shipping over $200 Members earn 5% back in store credit What is GHK-Cu
For best research handling practices, store this pre-formulated Aerosol spray in the refrigerator and keep the bottle tightly closed when not in use
How long would I need to stay on this medication
Although GHK-Cu has attracted significant attention due to its potential skin repair and anti-aging properties, the current commercial landscape does not provide sufficient financial incentives for a company to pursue an FDA New Drug Application (NDA)
This direct administration is particularly beneficial for individuals with malabsorption issues, such as those with pernicious anemia, Crohn's disease, or celiac disease
